Cargando…
Reversing stage III oral adenocarcinoma in a dog treated with anti-canine PD-1 therapeutic antibody: a case report
Monoclonal antibody targeting programmed cell death-1 (PD-1) is one of the most promising treatment therapies for human cancers. Canine PD-1 antibodies used in clinical trials have also shown efficacy in treating canine cancers. An 11-year-old male intact border collie presented to us for evaluation...
Autores principales: | Xu, Shuo, Xie, Jingshu, Wang, Shuaiyu, Tang, Na, Feng, Junli, Su, Youhong, Li, Gebin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219605/ https://www.ncbi.nlm.nih.gov/pubmed/37252387 http://dx.doi.org/10.3389/fvets.2023.1144869 |
Ejemplares similares
-
Prevalence, Risk Factors, Pathophysiology, Potential Biomarkers and Management of Feline Idiopathic Cystitis: An Update Review
por: He, Chengxi, et al.
Publicado: (2022) -
A Novel Canine Mammary Cancer Cell Line: Preliminary Identification and Utilization for Drug Screening Studies
por: Li, Rifei, et al.
Publicado: (2021) -
Proposal for a Histological Staging System of Mammary Carcinomas in Dogs and Cats. Part 1: Canine Mammary Carcinomas
por: Chocteau, Florian, et al.
Publicado: (2019) -
An Automated Canine Line-Up for Detection Dog Research
por: Aviles-Rosa, Edgar O., et al.
Publicado: (2021) -
An Assessment of the Stability of the Canine Oral Microbiota After Probiotic Administration in Healthy Dogs Over Time
por: Bell, Sara E., et al.
Publicado: (2020)